Sinopharm Group Co Ltd (X2S.MU)
| Previous close | 2.6200 |
| Open | 2.6200 |
| Bid | 2.5210 x 0 |
| Ask | 2.6190 x 0 |
| Day's range | 2.6200 - 2.6200 |
| 52-week range | 2.0680 - 2.8780 |
| Volume | |
| Avg. volume | 88 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Sinopharm Group Co Ltd's Dividend Analysis
Sinopharm Group Co Ltd (SHTDF) recently announced a dividend of $0.96 per share, payable on 2024-08-13, with the ex-dividend date set for 2024-06-17. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Sinopharm Group Co Ltd's dividend performance and assess its sustainability.
- Simply Wall St.
Exploring Top Dividend Stocks In Hong Kong June 2024
As of June 2024, the Hong Kong market faces challenges, notably marked by a 2.84% drop in the Hang Seng Index amidst broader global economic uncertainties and specific regional growth headwinds. This backdrop makes it particularly pertinent for investors to consider the stability offered by dividend-paying stocks, which can provide potential income and a degree of protection in volatile markets. In this context, understanding what constitutes a resilient dividend stock becomes crucial;...
- Simply Wall St.
Sinopharm Group Leads Three Premier Dividend Stocks In Hong Kong
As global markets navigate through varied economic signals, Hong Kong's stock market has shown resilience, with the Hang Seng Index recently marking a notable uptick. In this context, understanding the appeal of dividend stocks becomes particularly pertinent for investors looking for potential stability and steady returns amidst fluctuating market conditions.
